IPO Listed
Scribe Therapeutics IPO
US$129m raised
Lodged 23 Jul 2026 · NASDAQ: SCTX · US$15.00 cash per share
Advisers
Lead managers
- Bookrunner
- Legal adviser
- Issuer
- Scribe Therapeutics
- Issuer based in
- United States
- Listed
- 24 Jul 2026
- Sector
- Biotech
- Tags
- Biotech, Drug Development
In the league tables
Similar deals
- Jasper Therapeutics placement Jul 2026 · US$132m · Biotech
- Redx Pharma placement Aug 2026 · US$125m · Biotech
- Ambros Therapeutics placement Aug 2026 · US$150m · Biotech
- Werewolf Therapeutics placement Aug 2026 · US$150m · Biotech
- BlossomHill Therapeutics IPO Aug 2026 · US$150m · Biotech
Sources
- Jul 2026 Guggenheim Securities: Joint Bookrunner to Scribe Therapeutics on its Initial Public Offering and Concurrent Private Placement guggenheimsecurities.com
- 24 Jul 2026 Latham Advises on Scribe Therapeutics IPO lw.com
- 27 Jul 2026 Final IPO prospectus (424B4), Scribe Therapeutics, Inc. sec.gov


